Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Long-Term Deferred Tax (2023 - 2024)

Historic Long-Term Deferred Tax for Eton Pharmaceuticals (ETON) over the last 2 years, with Q4 2024 value amounting to $404000.0.

  • Eton Pharmaceuticals' Long-Term Deferred Tax rose 13905.33% to $404000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $404000.0, marking a year-over-year increase of 13905.33%. This contributed to the annual value of $404000.0 for FY2024, which is 13905.33% up from last year.
  • Eton Pharmaceuticals' Long-Term Deferred Tax amounted to $404000.0 in Q4 2024, which was up 13905.33% from $169000.0 recorded in Q4 2023.
  • Over the past 5 years, Eton Pharmaceuticals' Long-Term Deferred Tax peaked at $404000.0 during Q4 2024, and registered a low of $169000.0 during Q4 2023.